Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist

Journal of Pediatrics

Volumn 135, Issue 2 I, 1999, Pages 162-168

  Lustig, R H ^a   Rose, S R ^a   Burghen, G A ^a   Velasquez Mieyer, P ^a   Broome, D C ^a   Smith, K ^a   Li, H ^a   Hudson, M M ^a   Heideman, R L ^a   Kun, L E ^a  

^a Methodist Lebonheur Center of Children and Parents   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; INSULIN; LEPTIN; OCTREOTIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; BRAIN INJURY; CALORIC INTAKE; CHILD; CHOLELITHIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESPONSE; MALE; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0033497369     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70017-X     Document Type: Article

References (42)

1. M Rosenbaum RL Leibel J Hirsch Obesity N Engl J Med 337 1997 396 407
2. N Stahnke G Grubel I Lagenstein RP Willig Long-term follow-up of children with craniopharyngioma Eur J Pediatr 142 1984 179 185
3. M Didi E Didcock HA Davies AL Oligvy-Stuart JKH Wales SM Shalet High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia of childhood J Pediatr 127 1995 63 67
4. R Sorva Children with craniopharyngioma: early growth failure and rapid postoperative weight gain Acta Paediatr Scand 77 1988 587 592
5. GA Bray TF Gallagher Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature Medicine 54 1975 301 333
6. GA Bray Syndromes of hypothalamic obesity in man Pediatr Ann 13 1984 525 536
7. AG Reeves F Plum Hyperphagia, rage, and dementia accompanying a ventromedial hypothalamic neoplasm Arch Neurol 20 1972 616 624
8. B Jeanrenaud An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause Diabetologia 28 1985 502 513
9. TL Powley W Laughton Neural pathways involved in the hypothalamic integration of autonomic responses Diabetologia 20 1981 378 387
10. CA Sklar Craniopharyngioma: endocrine sequalae of treatment Pediatr Neurosurg 21 1994 120 123
11. E Ionescu F Rohner-Jeanrenaud HR Berthoud B Jeanrenaud Increases in plasma insulin levels in response to electrical stimulation of the dorsal motor nucleus of the vagus nerve Endocrinology 112 1983 904 910
12. GA Bray DA York Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis Physiol Rev 59 1979 719 809
13. F Rohner-Jeanrenaud B Jeanrenaud Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity Endocrinology 116 1985 830 834
14. AJ Krentz LM MacDonald DS Schade Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations Metabolism 43 1994 24 31
15. SWJ Lamberts AJ Van Der Lely WW De Herder LJ Hofland Drug therapy: octreotide N Engl J Med 334 1996 246 254
16. 2+ channels in the beta-cell J Biol Chem 266 1991 837 843
17. National Center for Health Statistics Health United States 1995 1995 Public Health Service Hyattsville (MD) 165 Publication No. 95-1232
18. VV Weldon SK Gupta G Klingensmith WL Clarke SC Duck MW Haymond Evaluation of growth hormone release in children using arginine and l -dopa in combination J Pediatr 87 1975 540 544
19. AL Rosenbloom L Wheeler R Bianchi FT Chin CM Tiwary A Grgic Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents Diabetes 24 1975 820 828
20. GC Weir A Sharma DH Zangen S Bonner-Weir Transcription factor abnormalities as a cause of beta cell dysfunction in diabetes: a hypothesis Acta Diabetol 34 1997 177 184
21. HR Berthoud B Jeanrenaud Acute hyperinsulinemia and its reversal by vagotomy following lesions of the ventromedial hypothalamus in anesthetized rats Endocrinology 105 1979 146 151
22. K Tokunaga M Fukushima JW Kemnitz GA Bray Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions Endocrinology 119 1986 1708 1711
23. S Inoue GA Bray The effect of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic lesions Endocrinology 100 1977 108 114
24. DK Smith J Sarfeh L Howard Truncal vagotomy in hypothalmic obesity Lancet 1 1983 1330 1331
25. A Bertoli R Magnaterra P Borboni MA Marini A Barini A Fusco Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity Horm Res 49 1998 17 21
26. L Orskov N Moiler JF Bak N Porksen O Schmitz Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus Metabolism 45 1996 211 217
27. B Guy-Grand Clinical studies with dexfenfluramine: from past to future Obes Res 3 1995 491S 496S
28. DH Ryan P Kaiser GA Bray Sibutramine: a novel new agent for obesity treatment Obes Res 3 1995 S553 S559
29. M Lunetta M Di Mauro R Le Moli S Burrafato Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans J Endocrinol Invest 19 1996 699 703
30. RB Simsolo S Ezzat JM Ong M Saghizadeh PA Kern Effects of acromegaly treatment and growth hormone on adipose tissue lipoprotein lipase J Clin Endocrinol Metab 80 1995 3233 3238
31. MA Simón B Romero C Calle Characterization of somatostatin binding sites in isolated rat adipocytes Regul Pept 23 1988 261 270
32. RM Campbell CG Scanes Inhibition of growth hormone-stimulated lipolysis by somatostatin, insulin, and insulin-like growth factors (somatomedins) in vitro Proc Soc Exp Biol Med 189 1988 362 366
33. S Misra K Sakamoto N Moustaid HS Sul Localization of sequences for the basal and insulin-like growth factor-1 inducible activity on the fatty acid synthase promoter in 3T3-L1 fibroblasts Biochem J 298 1994 575 578
34. EC Lotter R Krinsky JM McKay CM Treneer D Porte SC Woods Somatostatin decreases food intake of rats and baboons J Comp Physiol Psychol 95 1981 278 287
35. AS Levine JE Morley Peripherally administered somatostatin reduces feeding by a vagal mediated mechanism Pharmacol Biochem Behav 16 1982 897 902
36. SWJ Lamberts JC Reubi EP Krenning Somatostatin and the concept of peptide receptor scintigraphy in oncology Semin Oncol 21 1994 1 5
37. PB Kaplowitz AC Rundle SL Blethen Weight relative to height before and during growth hormone therapy in prepubertal children Horm Metab Res 30 1998 565 569
38. TG Ramsay Fat cells Endocrinol Metab Clin North Am 25 1996 847 870
39. LA Campfield FJ Smith G Mackie R Tenenbaum ML Sassano J Mullin Insulin normalization as an approach to the pharmacological treatment of obesity Obes Res 3 1995 591S 603S
40. R Alemzadeh G Langley L Upchurch P Smith AE Slonim Beneficial effect of diazoxide in obese hyperinsulinemic adults J Clin Endocrinol Metab 83 1998 1911 1915
41. Molloy PT, Berkowitz R, Stallings VA, Krell H, Sutton LN, Vaughan SN, et al. Pilot study of evaluation and treatment of tumor-related obesity in pediatric patients with hypothalamic/chiasmatic gliomas and craniopharyngiomas [abstract]. Eighth International Symposium on Neuro-oncology; 1998 May 6-9; Rome, Italy.
42. PW Mason J Petronio N Krawiecki J Whipple LR Meacham Use of dextroamphetamine for weight control in children following surgery for suprasellar tumors [abstract] Endocr Soc 80 1998 P1 P261